Daniel A. Pfeffer-Kleemann

Daniel A. Pfeffer-Kleemann

Auto-generated profile, based on publicly available information

Daniel A. Pfeffer-Kleemann

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
LDLi Y. Drake
Li Y. Drake
DPDaniel Pfeffer-Kleemann
Daniel Pfeffer-Kleemann
EZEmily Y. Zhang
Emily Y. Zhang
MNMaunick Lefin Koloko Ngassie
Maunick Lefin Koloko Ngassie
CPChristina M. Pabelick
Christina M. Pabelick
YPY. S. Prakash
Y. S. Prakash
Mechanical stretch associated with respiratory support can impair airway development and function in neonates, but the mechanisms are not fully understood. Using developing human airway smooth muscle cells exposed to cyclic forces with static stretch to mimic continuous positive airway pressure, we found that stretch dysregulates long-term cell proliferation and inflammatory cytokine production, and mechanosensitive Piezo ion channels may play a role in the proliferation response.

29 July 2026 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Open access
MNMaunick Lefin Koloko Ngassie
Maunick Lefin Koloko Ngassie
YOYamillie Ortiz
Yamillie Ortiz
PRPreetham Ravi
Preetham Ravi
DPDaniel A. Pfeffer-Kleemann
Daniel A. Pfeffer-Kleemann
SHSamantha K. Hamrick
Samantha K. Hamrick
YPY. S. Prakash
Y. S. Prakash
Iron is essential for cellular function, and lung cells are no exception. Previous studies have demonstrated an association between increased level of iron in the lung and aging and age-related lung diseases including pulmonary fibrosis and asthma in the elderly (AIE). However, the mechanisms underlying the accumulation of iron with aging or AIE, or the cell types involved, remain understudied. In the context of asthma, airway smooth muscle is a key cell type contributing to contractility as well as airway remodeling (proliferation, fibrosis). In this study we characterized iron level and regulation in human (hASM) from young (<45 yr), old (≥65 yr) and AIE (≥65 yr) male/female patients, and investigated the contribution of iron overload in hASM to airway remodeling. Cells were treated with ferric ammonium citrate (FAC) (100 μM; 72h) or iron chelator deferoxamine (DFO) (100 µM; 72h). Basal levels of intracellular ferrous iron (Fe 2+ ) were determined using the fluorescent dye FerroOrange. Cell lysates were analyzed for iron accumulation, antioxidant, lipid peroxidation, and extracellular matrix (ECM) markers, and cell proliferation was assessed. We found that iron accumulates with aging, but surprisingly decreases with AIE. hASM from AIE patients showed activated antioxidant pathways and lipid peroxidation, while FAC-exposure impaired iron metabolism and enhanced ECM deposition. Iron depletion mitigated the antioxidant response, lipid peroxidation, cell proliferation, ECM production. These findings suggest that iron metabolism in hASM contributes to cell hyperplasia and ECM, while in aging and particularly AIE, counter-regulatory changes in iron metabolism and antioxidant pathways occur, overall promoting airway remodeling.

27 June 2026 in Physiology
Verified
Journal Article
Closed access
MNMaunick Lefin Koloko Ngassie
Maunick Lefin Koloko Ngassie
YOYamillie Ortiz
Yamillie Ortiz
PRPreetham Ravi
Preetham Ravi
DPDaniel A. Pfeffer-Kleemann
Daniel A. Pfeffer-Kleemann
NBNiyati Borkar
Niyati Borkar
YPY. S. Prakash
Y. S. Prakash
Iron is an important metal element regulating biological processes such as gene expression, electron transport, cell proliferation, differentiation and division, and cellular respiration. Regulation of iron levels is therefore critical, with excess iron accumulation leading to iron-dependent lipid peroxidation and cell death (ferroptosis). Factors such as aging and environmental exposures (e.g. high/low oxygen, particulate iron) can disrupt iron homeostasis. Iron-dependent processes influence downstream pathways such as inflammation, mitochondrial energetics, and remodeling (proliferation, fibrosis): pathways involved in lung diseases particularly at the extremes of age: from hyperoxic lung injury in neonates to chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis (PF) that increase with age. While these diseases involve structural and functional changes in bronchial vs. alveolar compartments, including airway hyperreactivity, altered mucus production, cell proliferation and migration, increased extracellular matrix (ECM) remodeling, senescence and metabolic dysregulation, the casual or consequential links between iron dysregulation and disease pathology, particularly with aging, are still being investigated. The aim of this topical review is to (i) highlight current knowledge regarding iron regulation in normal lung vs. lung diseases, (ii) identify known roles of iron in lung homeostasis, and the contribution of iron dysregulation in lung diseases with aging, and (iii) explore the potential benefit of targeting iron regulation and/or ferroptosis in lung diseases.